Pre-market hot trades in US stocks: Ensysce Biosciences down 11.83% in pre-market; Onto Innovation up 9.50% in pre-market

Pre-market Hot Trades in US Stocks

Ensysce is down 11.83% in pre-market trading. Based on recent key news:

1. On August 6, Ensysce Biosciences completed the acquisition of Cy Biopharma, obtaining the clinical-stage candidate drug CY200. This transaction includes $17.1 million in cash and $21.5 million in a directed share issuance, driving the stock price to surge over 76% during trading. Source: Zhitong Finance

2. On August 6, Ensysce released an investor presentation introducing its protease-controlled opioid drug platforms TAAP and MPAR, emphasizing that its TAAP oxycodone product has received FDA breakthrough therapy designation, with plans to initiate a Phase 1b/3 study of PF614-MPAR in 2026. Source: Zhitong Finance

3. No other significant news recently. The biotechnology sector has been quite volatile lately and requires attention.

Onto Innovation is up 9.50% in pre-market trading. Based on recent key news:

1. On August 6, Onto Innovation announced its second-quarter financial report, with revenue of $343.129 million, exceeding market expectations of $325.2 million. Net income was $60.102 million, operating income was $63.55 million, gross margin was 53.4%, and earnings per share were $1.21. These excellent financial performances drove the stock price up.

2. On August 5, several investment firms, including Cantor Fitzgerald, raised their target price for Onto Innovation, reflecting a continued increase in capital expenditure demand for advanced nodes and packaging technologies. This positive analyst rating further boosted market confidence.

3. No other significant news recently. Industry capital expenditure demand is increasing, and market confidence is strengthening.

Top Gainers in Pre-market US Stocks

Jinxin Tech is up 151.89% in pre-market trading. Based on recent key news:

1. On August 5, the ADME-One high-throughput platform launched by Jinxin Tech is considered a major growth driver. The launch of this platform may drive the company's future performance growth, leading to a significant increase in stock price. Source: Zhitong Finance

2. No other significant news recently. The technology sector is driven by innovation, with increased volatility.

Big Tree Cloud is up 81.27% in pre-market trading. No significant news recently; trading is active, and capital flows are evident. Considering sector and industry trends, this stock shows significant volatility, and specific reasons need further observation. no_news

Doximity is up 67.81% in pre-market trading. Based on recent key news:

1. On August 6, Doximity reported first-quarter revenue of $156.6 million, exceeding market expectations of $151.7 million. The company also raised its revenue forecast for fiscal year 2027 to between $671 million and $681 million, slightly above Wall Street expectations This news drove the stock price to soar 73% in after-hours trading. Source: Reuters

2. On August 6, Doximity's net income for the first quarter was $24.315 million, with adjusted EBITDA of $74.8 million, exceeding market expectations of $69.6 million. This indicates strong performance in profitability, further boosting investor confidence. Source: Reuters

3. On August 6, Doximity's average analyst target price was raised from $25.68 to $26.21, reflecting market optimism about its future growth. Analysts unanimously rated it as "Buy," which also supported the stock price. Source: FactSet AI technology applications drive growth in the healthcare industry